As of January 23, 2025, Precipio (PRPO) has a market cap of $9.872 million USD. According to our data, Precipio is ranked No.8869 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $9.87 M |
20.22%
|
Dec 31, 2024 | $8.21 M |
-14.77%
|
Dec 29, 2023 | $9.64 M |
-41.02%
|
Dec 30, 2022 | $16.34 M |
-65.13%
|
Dec 31, 2021 | $46.84 M |
-23.67%
|
Dec 31, 2020 | $61.37 M |
0.98%
|
Dec 31, 2019 | $60.78 M |
-11.26%
|
Dec 31, 2018 | $68.48 M |
-87.17%
|
Dec 29, 2017 | $0.53 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Exact Sciences
EXAS
|
$10.14 B |
0.000 M
|
USA
|
Guardant Health
GH
|
$5.83 B |
0.000 M
|
USA
|
Natera
NTRA
|
$22.70 B |
-0.001 M
|
USA
|
NeoGenomics
NEO
|
$1.86 B |
0.000 M
|
USA
|
Myriad Genetics
MYGN
|
$1.12 B |
-0.000 M
|
USA
|
Adaptive Biotechnologies
ADPT
|
$1.18 B |
0.000 M
|
USA
|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
Hologic
HOLX
|
$16.07 B |
-0.000 M
|
USA
|
QuidelOrtho
QDEL
|
$2.99 B |
-0.000 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Market Cap | = | PRPO Stock Price | * | PRPO Shares Outstanding |
= | $6.66 | * | 1.48 M | |
= | $9.87 M |